<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Press Releases

Research    Press Releases    Funding    CCTSI

University of Colorado Anschutz Medical Campus Receives $54 Million From NIH

The National Institutes of Health has awarded $54 million over a seven-year period to the CCTSI at CU Anschutz. The grant from the National Center for Advancing Translational Sciences (NCATS) will fuel biomedical research and training across the state. This is the fourth consecutive time the NIH has funded the CCTSI since 2008 through its Clinical Translational Science Award (CTSA) program.


Author Wendy Meyer | Publish Date September 18, 2023
Full Story

Research    Press Releases    COVID-19    CCTSI

CU Researchers Show that Paxlovid Remains Highly Effective on Omicron Variants

Though many Coloradans are proceeding as though the COVID-19 pandemic is over, the virus continues to circulate, evolve and have an impact—especially for older adults and those with underlying medical conditions. Furthermore, because of the evolution of variants, doctors have fewer treatment options.


Author Wendy Meyer | Publish Date February 10, 2023
Full Story

Press Releases    COVID-19   

Nationwide study of 'Long COVID' to launch at University of Colorado Anschutz Medical Campus

The National Institutes of Health (NIH) has invested nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19. The Colorado Clinical and Translational Sciences Institute (CCTSI) is playing a major role in the initiative called REsearching COVID to Enhance Recovery or RECOVER.


Author Wendy Meyer | Publish Date February 07, 2022
Full Story

Colorado Clinical and Translational Sciences Institute (CCTSI) News Topics

Colorado Clinical and Translational Sciences Institute (CCTSI) In the News

CPR

Kate Showalter knew that cancer might come for her, ever since it took her mother’s life in 2002.

news outletCPR
Publish DateJune 19, 2024

The primary objective of this study is to evaluate PAP’s effects on depression, anxiety, and existential distress (demoralization and death anxiety). The baseline and screening visits are done in the CCTSI’s outpatient CTRC.

Full Story
Self

Supplements That Promise to Make You Prettier, Healthier, Better Are Everywhere. Here’s What the Science Says

news outletSelf
Publish DateJune 18, 2024

“Best case scenario: You just pee it out,” Aimee Bernard, PhD, an assistant professor in the Department of Immunology & Microbiology at the University of Colorado Anschutz Medical Campus and Co-Director of Communicating Your Science to the Public at the CCTSI, tells SELF.

Full Story
CNN

‘Ozempic babies’: Reports of surprise pregnancies raise new questions about weight loss drugs

news outletCNN
Publish DateMay 13, 2024

Dr. Melanie Cree is now conducting a larger and longer clinical trial, funded by the NIH, focusing on fertility outcomes for young women with PCOS who take semaglutide. The study will be held at CCTSI’s CHCO CTRC.

Full Story
The Colorado Sun

How doctors in Denver helped pioneer research on a new drug for food allergies

news outletThe Colorado Sun
Publish DateMarch 28, 2024

Researchers at National Jewish Health conducted some of the earliest studies on using anti-IgE drugs to prevent severe allergic reactions to food 

Full Story